Henrique Bittencourt Selected Research

Stem Cell Transplantation

7/2014	Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.
2/2014	Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrique Bittencourt Research Topics

Disease

12	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 04/2002
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2014
9	Neoplasms (Cancer) 01/2022 - 01/2018
6	Leukemia 01/2022 - 01/2016
4	Infections 01/2021 - 04/2002
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2021
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 01/2020
2	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2019
2	Residual Neoplasm 12/2021 - 08/2017
2	Cytokine Release Syndrome 01/2018 - 01/2018
1	Down Syndrome (Down's Syndrome) 01/2022
1	Necrosis 01/2022
1	Philadelphia Chromosome 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Hemorrhagic Cystitis 01/2017
1	Wiskott-Aldrich Syndrome 01/2017
1	Pathologic Complete Response 01/2016
1	Choristoma (Ectopic Tissue) 02/2014
1	Juvenile Myelomonocytic Leukemia 09/2013
1	Renal Insufficiency (Renal Failure) 03/2013
1	Neutropenia 03/2013
1	Mucositis 05/2012
1	Stomatitis 05/2012
1	Fever (Fevers) 01/2011
1	Febrile Neutropenia 01/2011
1	Anorexia 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2010
1	Myeloid Sarcoma (Chloroma) 01/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2005
1	Bacterial Infections (Bacterial Infection) 12/2002

Drug/Important Bio-Agent (IBA)

6	Busulfan (Busulfex)FDA Link 01/2022 - 01/2009
4	tisagenlecleucelIBA 01/2022 - 01/2018
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 04/2002
3	Chimeric Antigen ReceptorsIBA 11/2021 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 04/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	SteroidsIBA 02/2014 - 09/2013
2	Interleukin-10 (Interleukin 10)IBA 05/2010 - 12/2002
1	TransferasesIBA 01/2022
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	CreatinineIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	ruxolitinibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	NucleotidesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Surface Antigens (Surface Antigen)IBA 10/2018
1	AntigensIBA 10/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Clofarabine (Clolar)FDA Link 01/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Cytochrome P-450 CYP2C9IBA 01/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2014
1	Calcineurin InhibitorsIBA 07/2014
1	Sirolimus (Rapamycin)FDA Link 07/2014
1	Rituximab (Mabthera)FDA Link 07/2014
1	remestemcel-lIBA 02/2014
1	Hemoglobins (Hemoglobin)IBA 03/2013
1	CytokinesIBA 05/2012
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2011
1	ProcalcitoninIBA 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2011
1	Interleukin-8 (Interleukin 8)IBA 01/2011
1	EnzymesIBA 01/2010
1	Imatinib Mesylate (Gleevec)FDA Link 02/2005
1	Fc gamma receptor IIAIBA 12/2002
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2002

Therapy/Procedure

14	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2010
9	Therapeutics 01/2021 - 02/2005
7	Transplantation 01/2018 - 09/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2010 - 04/2002
2	Cell Transplantation 01/2022 - 01/2017
2	Stem Cell Transplantation 07/2014 - 02/2014
1	Investigational Therapies (Experimental Therapy) 08/2017
1	Renal Dialysis (Hemodialysis) 03/2013
1	Transcutaneous Electric Nerve Stimulation (TENS) 05/2012